St. Luke's Customized Coding Seminar (2018)
Practice Gap: New CPT and ICD-10-CM codes have been introduced and physicians and the staff of urology practices do not have the knowledge to accurately apply correct codes for diseases, signs and symptoms, and external causes of injury or disease.
Educational Need: Physicians and staff in urology practices need training to understand and apply the new CPT and ICD-10-CM codes to ensure procedures are properly coded for accurate billing.
- Practice Manager
- Nurse Practitioner
- Physician Assistant
- Medical Technician
After completing this activity, particpants will be able to:
- List the 2018 CPT changes affecting urologists
- Determine coding for the appropriate level of evaluation and management services
- Describe proper use of modifiers to apply in everyday practice
- Determine proper coding for urology services
- Describe the relationship between encounter documentation and code selection
Enda Maldonado; AUA Coding Educator: Nothing to Disclose
Joel Dunay; Senior Manager, AUA Practice Management Department: Nothing to Disclose
Victor Nitti, MD; Chair, AUA Office of Education: Serenity Pharmaceticals, Investtment Interest
Brant Inman, MD: Chair, AUA Content Review Work Group: Combat Medical, Consultant/Advisor; BioCancell, Consultant/Advisor; Nucleix, Scientific Study/Trial; Urogen, Scientific Study/Trial
Accreditation: The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation: The American Urological Association designates this live activity for a maximum of 3.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other Learners: The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.
Evidence Based Content: It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.
AUA Disclosure Policy: All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.
Resolution of Identified Conflict of Interest: All disclosures will be reviewed by the program/course directors or editors for identification of conflicts of interest. Peer reviewers, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:
- Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or Education Content Review Committee or its subgroup.
- Limit content to evidence with no recommendations
- Introduction of a debate format with an unbiased moderator (point-counterpoint)
- Inclusion of moderated panel discussion
- Publication of a parallel or rebuttal article for an article that is felt to be biased
- Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
- Divestiture of the relationship by faculty
Off-label or Unapproved Use of Drugs or Devices: The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.
- 3.75 AMA PRA Category 1 Credit™
- 3.75 Non-Physician Participation